Style | Citing Format |
---|---|
MLA | Hamta A, et al.. "Factors Affecting the Antimonial Treatment Duration Rate in Patients With Cutaneous Leishmaniasis: Survival Analysis Model." Tehran University Medical Journal, vol. 78, no. 6, 2020, pp. 388-396. |
APA | Hamta A, Saghafipour A, Mozaffari E, Salemi Z (2020). Factors Affecting the Antimonial Treatment Duration Rate in Patients With Cutaneous Leishmaniasis: Survival Analysis Model. Tehran University Medical Journal, 78(6), 388-396. |
Chicago | Hamta A, Saghafipour A, Mozaffari E, Salemi Z. "Factors Affecting the Antimonial Treatment Duration Rate in Patients With Cutaneous Leishmaniasis: Survival Analysis Model." Tehran University Medical Journal 78, no. 6 (2020): 388-396. |
Harvard | Hamta A et al. (2020) 'Factors Affecting the Antimonial Treatment Duration Rate in Patients With Cutaneous Leishmaniasis: Survival Analysis Model', Tehran University Medical Journal, 78(6), pp. 388-396. |
Vancouver | Hamta A, Saghafipour A, Mozaffari E, Salemi Z. Factors Affecting the Antimonial Treatment Duration Rate in Patients With Cutaneous Leishmaniasis: Survival Analysis Model. Tehran University Medical Journal. 2020;78(6):388-396. |
BibTex | @article{ author = {Hamta A and Saghafipour A and Mozaffari E and Salemi Z}, title = {Factors Affecting the Antimonial Treatment Duration Rate in Patients With Cutaneous Leishmaniasis: Survival Analysis Model}, journal = {Tehran University Medical Journal}, volume = {78}, number = {6}, pages = {388-396}, year = {2020} } |
RIS | TY - JOUR AU - Hamta A AU - Saghafipour A AU - Mozaffari E AU - Salemi Z TI - Factors Affecting the Antimonial Treatment Duration Rate in Patients With Cutaneous Leishmaniasis: Survival Analysis Model JO - Tehran University Medical Journal VL - 78 IS - 6 SP - 388 EP - 396 PY - 2020 ER - |